INPLASY202480120

Long-term survival outcomes of first-line immune checkpoint inhibitor in PD-L1 negative metastatic non-small cell lung cancer

Keywords: NSCLC; immunotherapy; immune checkpoint inhibitor; survival outcome; overall survival; progression-free survival; lung cancer.

Download PDF - 202480120

Review Status: completed but not published